ANNA KEADY: Open Payments
NPI 1609440056 · CLAREMONT, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 36 payments from 14 companies in 2025. Trend: 2023 $1,543 · 2024 $513 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $289 |
| AstraZeneca Pharmaceuticals LP | 3 | $162 |
| Novo Nordisk Inc | 5 | $120 |
| Vanda Pharmaceuticals Inc. | 2 | $70 |
| PFIZER INC. | 2 | $58 |
| Baxter Healthcare | 1 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Ascendis Pharma Endocrinology Inc | 1 | $28 |
| Exact Sciences Corporation | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
Products named: UBRELVY, AIRSUPRA, QULIPTA, Wegovy, FANAPT, Hillrom - Carnation Ambulatory Monitor, NURTEC ODT, LINZESS.
Industry payments across NH — which companies pay providers there.
